SMi are delighted to announce that Simon Wandel, Expert Statistical Methodologist from Novartis has joined the expert panel on day one, his presentation is entitled: Bayesian approaches in practice: Examples from early phase Oncology trials, looking at the following areas:
• Prior derivation the (robust) meta-analytic-predictive approach
• Using historical control data in phase II
• Tailored multi-strata designs
• Lessons learned from more than 100 Bayesian adaptive trials
Click here for more information and to see the full programme.
SMi’s Interview with EMD Serono:
In the run up to the 7th annual Adaptive Designs in Clinical trials conference, industry KOL Alex Sverdlov, Associate Director of Biostatistics, EMD Serono was asked a few questions on his views on the current challenges and developments within the Adaptive Designs industry, including:
• How is the area of Response-Adaptive Randomization trial designs advancing clinical trial designs?
• How does Response –Adaptive Randomisation effect better treatment allocation for patients?
• There has been much controversy surrounding the use of placebos and traditional approaches to find a curable vaccine for Ebola: How can adaptive clinical trials be more advantageous?
• What new developments do you envision for adaptive designs in clinical trials for 2015? How can this be actioned sooner rather than later?
Adaptive Designs in Clinical trials 2015 will provide the opportunity to discover new opportunities in a dedicated session of new innovation under the spotlight featuring:
• Novel Response-Adaptive Randomization Designs for multi-armed survival trials
• Covariate-Adjusted Response-Adaptive Randomization Designs
• Group Sequential Response-Adaptive Designs
• Multi-Armed Bayesian Bandit Models in rare disease
• Seamless Adaptive Designs for estimating treatment effects
This conference will enable attendees to network with some of our leading experts in novel clinical trials designs and discuss current challenges surrounding urgent unmet medical meets, such as the Ebola crisis and clinical attrition rates in Alzheimer's disease and Cancer Treatment.
Book by 27th February to save £100
Click here for more information or to register.
Alternatively, contact Magdalena Georgieva on +44 (0)20 7827 6148 or email mgeorgieva@smi-online.co.uk
--------------- END ---------------
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk